MISSISSAUGA, ON, Nov. 11, 2011 /CNW/ - YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported operational and financial results for its first quarter of fiscal 2012, ended September 30, 2011.
YM BioSciences reports operational and financial results for the first quarter of fiscal 2012